Deloitte Advises Sina Drug in PharMerica Investment
Deloitte Corporate Finance acted as the exclusive financial advisor to Sina Drug in its investment from PharMerica.
February 5, 2014
Deloitte Corporate Finance | PharMerica Corporation | Sina Drug Corporation
ABF Journal